← FDA Drug Approvals (Drugs@FDA)

ACETAMINOPHEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2020-08-07

Drug application

FDA Application #

ANDA213255

Application type

Abbreviated New Drug Application (Generic)

Brand name

ACETAMINOPHEN

Generic name

ACETAMINOPHEN

Active ingredients

ACETAMINOPHEN

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

MYLAN

Manufacturer

Mylan Institutional LLC

First approval

2020-08-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown